Liposome News and Research

Latest Liposome News and Research

National Jewish Health's liposome-based vaccine receives US patent

National Jewish Health's liposome-based vaccine receives US patent

Phase I/II DIGNITY trial abstract of ThermoDox accepted for poster session at 2010 Breast Cancer Symposium

Phase I/II DIGNITY trial abstract of ThermoDox accepted for poster session at 2010 Breast Cancer Symposium

Celsion receives SBIR grant to develop heat sensitive liposomal technology for cancer treatment

Celsion receives SBIR grant to develop heat sensitive liposomal technology for cancer treatment

Celator Pharmaceuticals raises $20 million in Series D private equity financing

Celator Pharmaceuticals raises $20 million in Series D private equity financing

NeoPharm second-quarter net loss decreases to $0.8 million

NeoPharm second-quarter net loss decreases to $0.8 million

FDA grants Fast Track Designation to Celsion's ThermoDox for liver cancer treamtment

FDA grants Fast Track Designation to Celsion's ThermoDox for liver cancer treamtment

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

Nanoparticle-based gene silencing system inhibits angiogenesis process in tumor growth

Nanoparticle-based gene silencing system inhibits angiogenesis process in tumor growth

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

NCI panel recommends Celsion's Phase III ThermoDox HEAT Study as Priority Clinical Trial for HCC

NCI panel recommends Celsion's Phase III ThermoDox HEAT Study as Priority Clinical Trial for HCC

Celsion reports net loss of $2.6M for second-quarter 2010

Celsion reports net loss of $2.6M for second-quarter 2010

Toxic protein in bee venom improves liposome encapsulated drug effectiveness

Toxic protein in bee venom improves liposome encapsulated drug effectiveness

Bio-Path commences dosing in Liposomal Grb-2 Phase I cancer study

Bio-Path commences dosing in Liposomal Grb-2 Phase I cancer study

Gilead Sciences second-quarter total revenues increase 17% to $1.93 billion

Gilead Sciences second-quarter total revenues increase 17% to $1.93 billion

Arsenic nanoparticle to combat aggressive type of breast cancer prevalent in young women

Arsenic nanoparticle to combat aggressive type of breast cancer prevalent in young women

URI engineers develop new controlled drug delivery system using nanoparticles embedded in liposome

URI engineers develop new controlled drug delivery system using nanoparticles embedded in liposome

Scientists discover nanoparticle to deliver DNA with minimum toxic effect

Scientists discover nanoparticle to deliver DNA with minimum toxic effect

Survey: 66% of patients with metastatic colorectal cancer are now tested for KRAS

Survey: 66% of patients with metastatic colorectal cancer are now tested for KRAS

Celator announces expansion of research agreement with Cephalon

Celator announces expansion of research agreement with Cephalon

Stimuvax clinical program resumed in patients with NSCLC

Stimuvax clinical program resumed in patients with NSCLC